search
Back to results

Endovascular Therapy in Acute Ischaemic Stroke Due to Large Vessel Occlusion

Primary Purpose

Acute Ischaemic Stroke

Status
Completed
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Aspiration First
Stent retriever first
Sponsored by
The University of Hong Kong
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Ischaemic Stroke focused on measuring Endovascular therapy, Mechanical thrombectomy, Acute ischaemic stroke treatment

Eligibility Criteria

undefined - 80 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Onset: ≤ 4.5 hours from symptoms onset
  • Age < 80
  • Premorbid modified Rankin Score (mRS) ≤ 2
  • NIHSS 8 - 29
  • Clear and definite symptoms and signs suggesting stroke with hemiparesis as one of the presenting symptoms
  • Plain CT brain showed no evidence of intracerebral haemorrhage and ASPECTS ≥ 7
  • Multiphasic CT angiogram confirmed proximal vessel occlusion at internal carotid artery (ICA), carotid T junction, proximal middle cerebral artery (M1 segment to proximal M2 with loss of all M2 branches), proximal anterior cerebral artery (segment A1) or basilar artery

Exclusion Criteria:

  • Interventionist or angio-laboratory not available
  • Neurological signs rapidly resolving
  • NIHSS>29
  • Evidence of cerebral haemorrhage or subarachnoid haemorrhage on CT brain
  • ASPECTS<7
  • Excessive tortuosity of the vessel precluding device delivery
  • Known chronic renal failure with creatinine level >250umol/L
  • Known haemorrhagic diathesis
  • Known coagulation factor deficiency
  • Difficult blood pressure control with persistent systolic blood pressure >185mg or diastolic blood pressure >110mg despite aggressive blood pressure lowering therapy
  • On anticoagulant and INR≥3
  • On heparin in previous 48 hour and APTT>2x of normal
  • Platelet counts <30
  • Blood glucose <2.7mmol/L
  • Known severe allergies to contrast medium
  • Seizure as presenting symptoms with post-ictal hemiparesis
  • Life expectancy < 3months
  • Pregnant

Sites / Locations

  • Queen Mary Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Aspiration First

Stent retriever first

Arm Description

Aspiration thrombectomy with large bore catheters

Thrombectomy with a licensed stent retriever device

Outcomes

Primary Outcome Measures

Modified Rankin scale
The primary outcome is 90 days modified Rankin scale. The modified Rankin scale is a 7-point scale ranging from 0 (no symptoms) to 6 (death). A score of 2 or less indicates functional independence.

Secondary Outcome Measures

National Institute of Health Stroke Severity Score (NIHSS)
NIHSS score at 24 hours and at 7 day or discharge if earlier. NIHSS score describe the clinical severity of stroke symptoms, and is scored from 0 (no symptoms) to 42 (most severe deficits). The total NIHSS score before, at 24 hours after intervention and subsequent follow up will be assessed.
Activities of daily living
Activities of daily living measured using modified Barthel index (mBI). modified Barthel Index is a measurement of independence of daily living, the score ranges from 0 to 100, with higher score correlating to better outcome.
Percentage of successful recanalization
Percentage of successful recanalization, defined as modified Thrombolysis in Cerebral Infarction (mTICI) of 2b (more that 50% of distal branches visible) or 3 (all distal branches visible) assessed at the end of procedure

Full Information

First Posted
October 17, 2017
Last Updated
September 27, 2019
Sponsor
The University of Hong Kong
Collaborators
Queen Mary Hospital, Hong Kong, Ruttonjee Hospital, Hong Kong
search

1. Study Identification

Unique Protocol Identification Number
NCT03328403
Brief Title
Endovascular Therapy in Acute Ischaemic Stroke Due to Large Vessel Occlusion
Official Title
Endovascular Therapy in Acute Ischaemic Stroke Due to Large Vessel Occlusion
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
September 17, 2015 (Actual)
Primary Completion Date
September 2019 (Actual)
Study Completion Date
September 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Hong Kong
Collaborators
Queen Mary Hospital, Hong Kong, Ruttonjee Hospital, Hong Kong

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
Aim of Study: To develop a standardized patient selection criteria and imaging protocol for endovascular therapy in acute ischaemic stroke (AIS) To create a local efficacy and safety database for intra-arterial mechanical thrombectomy devices use To establish predictors for poor functional outcome despite successful recanalization Study Design: Prospective Subject and Site: 100 acute ischaemic stroke patients with large vessel occlusion At Queen Mary and Ruttonjee Hospital, Hong Kong Duration of participation: 2 years Entry Criteria: Subject must meet all inclusion criteria and none of the exclusion criteria Consent: Both English and Chinese versions of Informed consent are available and will be obtained from patient or his/her next of kin
Detailed Description
Our study aim to set a standard patient selection and imaging protocol based on previous positive trials for endovascular therapy in AIS patients. Local efficacy and safety data of the FDA mechanical devices mainly Penumbra Aspiration System and Solitaire Flow Restoration device will be collected to create a local database for future service development. Clinical predictors for poor clinical outcomes despite successful recanalization will be looked for. Intra-arterial treatment consisted of arterial catheterization with a micro-catheter and micro-guide wire to the level of occlusion. Mechanical treatment could involve thrombus aspiration technique or use of a retrievable stent. The method of intra-arterial treatment will leave to the discretion of the involved interventionist. Only devices that have received U.S. Food and Drug Administration (FDA) or Conformite Europeenne (CE) approval will be used in the trial. One or more members of each intervention team have to have completed at least five full procedures with a particular type of device. Outcome and Safety Measures: The primary outcome is 90 days modified Rankin scale. The modified Rankin scale is a 7-point scale ranging from 0 (no symptoms) to 6 (death). A score of 2 or less indicates functional independence. Secondary outcomes include: NIHSS score at 24 hours and at 7 day or discharge if earlier Activities of daily living measured using Barthel index and NIHSS at 90 days Percentage of successful recanalization, defined as modified Thrombolysis in Cerebral Infarction (mTICI) of 2b (more that 50% of distal branches visible) or 3 (all distal branches visible) assessed at the end of procedure Efficacy of work flow with time measure on onset to CT, CT to groin puncture, puncture to reperfusion and number of pass of device before successful recanalization Final infarct volume measured by plain CT brain at 3 days after procedure Death

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Ischaemic Stroke
Keywords
Endovascular therapy, Mechanical thrombectomy, Acute ischaemic stroke treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients will be randomized to use either the Aspiration System or one of the stent-retreivers (Trevo / Solitaire) first. Other devices would be used if the first device failed to open the occluded vessel satisfactorily, depending on clinical situation and the involved interventionists' preferences.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
58 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Aspiration First
Arm Type
Experimental
Arm Description
Aspiration thrombectomy with large bore catheters
Arm Title
Stent retriever first
Arm Type
Experimental
Arm Description
Thrombectomy with a licensed stent retriever device
Intervention Type
Device
Intervention Name(s)
Aspiration First
Intervention Description
Use aspiration system (mainly Penumbra) first, other devices would be used if the first device failed to open the occluded vessel satisfactorily, depending on clinical situation and the involved interventionists' preferences.
Intervention Type
Device
Intervention Name(s)
Stent retriever first
Intervention Description
Use one of the stent retrievers (Trevo / Solitaire) first, other devices would be used if the first device failed to open the occluded vessel satisfactorily, depending on clinical situation and the involved interventionists' preferences.
Primary Outcome Measure Information:
Title
Modified Rankin scale
Description
The primary outcome is 90 days modified Rankin scale. The modified Rankin scale is a 7-point scale ranging from 0 (no symptoms) to 6 (death). A score of 2 or less indicates functional independence.
Time Frame
90 days
Secondary Outcome Measure Information:
Title
National Institute of Health Stroke Severity Score (NIHSS)
Description
NIHSS score at 24 hours and at 7 day or discharge if earlier. NIHSS score describe the clinical severity of stroke symptoms, and is scored from 0 (no symptoms) to 42 (most severe deficits). The total NIHSS score before, at 24 hours after intervention and subsequent follow up will be assessed.
Time Frame
At 24 hours and at 7 day or discharge if earlier
Title
Activities of daily living
Description
Activities of daily living measured using modified Barthel index (mBI). modified Barthel Index is a measurement of independence of daily living, the score ranges from 0 to 100, with higher score correlating to better outcome.
Time Frame
90 days
Title
Percentage of successful recanalization
Description
Percentage of successful recanalization, defined as modified Thrombolysis in Cerebral Infarction (mTICI) of 2b (more that 50% of distal branches visible) or 3 (all distal branches visible) assessed at the end of procedure
Time Frame
1 day

10. Eligibility

Sex
All
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Onset: ≤ 4.5 hours from symptoms onset Age < 80 Premorbid modified Rankin Score (mRS) ≤ 2 NIHSS 8 - 29 Clear and definite symptoms and signs suggesting stroke with hemiparesis as one of the presenting symptoms Plain CT brain showed no evidence of intracerebral haemorrhage and ASPECTS ≥ 7 Multiphasic CT angiogram confirmed proximal vessel occlusion at internal carotid artery (ICA), carotid T junction, proximal middle cerebral artery (M1 segment to proximal M2 with loss of all M2 branches), proximal anterior cerebral artery (segment A1) or basilar artery Exclusion Criteria: Interventionist or angio-laboratory not available Neurological signs rapidly resolving NIHSS>29 Evidence of cerebral haemorrhage or subarachnoid haemorrhage on CT brain ASPECTS<7 Excessive tortuosity of the vessel precluding device delivery Known chronic renal failure with creatinine level >250umol/L Known haemorrhagic diathesis Known coagulation factor deficiency Difficult blood pressure control with persistent systolic blood pressure >185mg or diastolic blood pressure >110mg despite aggressive blood pressure lowering therapy On anticoagulant and INR≥3 On heparin in previous 48 hour and APTT>2x of normal Platelet counts <30 Blood glucose <2.7mmol/L Known severe allergies to contrast medium Seizure as presenting symptoms with post-ictal hemiparesis Life expectancy < 3months Pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mona Man-Yu Tse, MBBS, FHKAM
Organizational Affiliation
Queen Mary Hospital, Hong Kong
Official's Role
Principal Investigator
Facility Information:
Facility Name
Queen Mary Hospital
City
Hong Kong
Country
Hong Kong

12. IPD Sharing Statement

Learn more about this trial

Endovascular Therapy in Acute Ischaemic Stroke Due to Large Vessel Occlusion

We'll reach out to this number within 24 hrs